Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
University of Southern California
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia
City of Hope Medical Center
RWTH Aachen University
Italfarmaco
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Sierra Oncology LLC - a GSK company
Fred Hutchinson Cancer Center
Italfarmaco
M.D. Anderson Cancer Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Galena Biopharma, Inc.
Icahn School of Medicine at Mount Sinai
Hospital Israelita Albert Einstein
Geron Corporation
Northside Hospital, Inc.
Mayo Clinic
Teva Branded Pharmaceutical Products R&D, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
University of California, San Francisco
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Copenhagen University Hospital at Herlev
Case Comprehensive Cancer Center
Hoag Memorial Hospital Presbyterian